Lupin-Q4 Results
One of the leading Indian drug maker company Lupin’s net profit-profit post tax- grew 18.2 percent year-on-year (YoY) to Rs…
Read MoreOne of the leading Indian drug maker company Lupin’s net profit-profit post tax- grew 18.2 percent year-on-year (YoY) to Rs…
Read MoreThe six debt schemes of Franklin Templeton Mutual Fund with assets of around Rs.26,000 crores were frozen on 23 April…
Read MoreThe second wave of pandemic in India has brought nervousness among FPIs which is visible in the flow numbers for…
Read MoreAs per Income Tax Act, there are limits to the cash transactions entered into by a person or an entity.…
Read MoreFincare Small Finance Bank-Fincare SFB, on Sunday filed a draft preliminary prospectus with the markets regulator Securities Exchange Board of…
Read MoreCovid-19 has changed the perspective of masses towards life insurance policies. Cost of hospitalization could be quite high and in…
Read MoreCBDT via a circular dated March 12, 2021 provided for the reporting of a certain transactions to the Income Tax…
Read MoreCovid-19 is not showing any signs of loosening its grip in India. With daily cases crossing 4 lakhs and thousands…
Read More